These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15357490)

  • 61. [Clinical significance of transaminases. I. Review of the literature].
    SOLIANI F
    Osp Ital Chir; 1961 Sep; 5():343-69. PubMed ID: 13914944
    [No Abstract]   [Full Text] [Related]  

  • 62. Cell damage enzymes and clinical acumen.
    LEE RA; SMITH J; DIERKS C; MASON EE
    J Iowa State Med Soc; 1960 Jan; 50():8-10. PubMed ID: 14415206
    [No Abstract]   [Full Text] [Related]  

  • 63. Experiences with transaminase determinations in coronary disease.
    STEINBERG MS
    J Am Osteopath Assoc; 1955 Feb; 55(6):383-4. PubMed ID: 13286152
    [No Abstract]   [Full Text] [Related]  

  • 64. [Normal values of various liver function tests].
    BALLVE MR
    Med Cir Farm; 1955 Oct; (234):466-71. PubMed ID: 13279433
    [No Abstract]   [Full Text] [Related]  

  • 65. [Treatment of patients with normal liver aminotransferases].
    González Ballerga E; Levi D; Reggiardo V
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S50-2. PubMed ID: 20214303
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of cirrhotics].
    Galdame O; Jorge A; Sordá J
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S42-5. PubMed ID: 20214300
    [No Abstract]   [Full Text] [Related]  

  • 67. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
    Hrachovec J; Patel P
    Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198
    [No Abstract]   [Full Text] [Related]  

  • 68. [Antiviral treatment in liver cirrhosis due to hepatitis C virus].
    Martínez-Bauer E; Forns X
    Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104
    [No Abstract]   [Full Text] [Related]  

  • 69. [Due to normal transaminase values, no further treatment. Hepatitis C patient "suddenly" has liver cirrhosis].
    MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357490
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effectiveness of long-acting interferon (peginterferon)].
    Kondo Y; Tateishi R; Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of patients with chronic hepatitis C who never had been treated].
    Hézode C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B38-49. PubMed ID: 12180307
    [No Abstract]   [Full Text] [Related]  

  • 72. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract]   [Full Text] [Related]  

  • 73. [Therapy of chronic hepatitis C].
    Moradpour D; Blum HE
    Praxis (Bern 1994); 2006 Sep; 95(38):1451-7. PubMed ID: 17058595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [New therapeutic agents for chronic hepatitis C].
    Hiramatsu N; Hayashi N
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):170-7. PubMed ID: 14968593
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.